MOODY LYNN & LIEBERSON, LLC - AVALO THERAPEUTICS INC ownership

AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F108. A total of 76 filers reported holding AVALO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
MOODY LYNN & LIEBERSON, LLC ownership history of AVALO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$5,000
-28.6%
10,0000.0%0.00%
-100.0%
Q1 2022$7,000
-58.8%
10,0000.0%0.00%0.0%
Q4 2021$17,00010,0000.00%
Other shareholders

There were no reported owners of AVALO THERAPEUTICS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of AVALO THERAPEUTICS INC shareholders